| 000 | 01181 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514011619.0 | ||
| 264 | 0 | _c20020208 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a1040-8428 | ||
| 024 | 7 |
_a10.1016/s1040-8428(01)00132-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReff, M E | |
| 245 | 0 | 0 |
_aA review of modifications to recombinant antibodies: attempt to increase efficacy in oncology applications. _h[electronic resource] |
| 260 |
_bCritical reviews in oncology/hematology _cOct 2001 |
||
| 300 |
_a25-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacokinetics |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoconjugates _xpharmacokinetics |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aProtein Engineering |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacokinetics |
| 700 | 1 | _aHeard, C | |
| 773 | 0 |
_tCritical reviews in oncology/hematology _gvol. 40 _gno. 1 _gp. 25-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1040-8428(01)00132-9 _zAvailable from publisher's website |
| 999 |
_c11500459 _d11500459 |
||